{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:19:15Z","timestamp":1791303555540,"version":"4.1.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1097\/inf.0b013e31823096a8","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T14:39:10Z","timestamp":1317739150000},"page":"37-41","source":"Crossref","is-referenced-by-count":139,"title":["Antibiotic Treatment of Escherichia coli O157 Infection and the Risk of Hemolytic Uremic Syndrome, Minnesota"],"prefix":"10.1097","volume":"31","author":[{"given":"Kirk E.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Wilker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"Reiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin B.","family":"Hedican","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff B.","family":"Bender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig W.","family":"Hedberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210202","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1086\/319269","article-title":". The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings.","volume":"183","author":"Banatvala","year":"2001","journal-title":"J Infect Dis"},{"key":"R3-9-20210202","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1203\/00006450-200108000-00002","article-title":"Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome.","volume":"50","author":"Proulx","year":"2001","journal-title":"Pediatr Res"},{"key":"R4-9-20210202","first-page":"1073","article-title":"Shiga-toxin-producing Escherichia coli and haemolytic uremic syndrome.","volume":"365","author":"Tarr","year":"2005","journal-title":"Lancet"},{"key":"R5-9-20210202","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa011033","article-title":". Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome.","volume":"346","author":"Chandler","year":"2002","journal-title":"N Engl J Med"},{"key":"R6-9-20210202","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s004670100660","article-title":"Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome.","volume":"16","author":"Ray","year":"2001","journal-title":"Pediatr Nephrol"},{"key":"R7-9-20210202","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1086\/322598","article-title":". The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients.","volume":"33","author":"Dundas","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R8-9-20210202","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/infdis\/151.5.775","article-title":". The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.","volume":"151","author":"Karmali","year":"1985","journal-title":"J Infect Dis"},{"key":"R9-9-20210202","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(83)91795-6","article-title":". Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools.","volume":"1","author":"Karmali","year":"1983","journal-title":"Lancet"},{"key":"R10-9-20210202","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1994.03520170059036","article-title":". A multistate outbreak of Escherichia coli O157:H7-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers. The Washington experience.","volume":"272","author":"Bell","year":"1994","journal-title":"JAMA"},{"key":"R11-9-20210202","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.1542\/peds.100.1.e12","article-title":". Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections.","volume":"100","author":"Bell","year":"1997","journal-title":"Pediatrics"},{"key":"R13-9-20210202","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1056\/NEJM200006293422601","article-title":". The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections.","volume":"342","author":"Wong","year":"2000","journal-title":"N Engl J Med"},{"key":"R14-9-20210202","first-page":"357","article-title":". Effect of early fosfomycin treatment of prevention of hemolytic uremic syndrome accompanying Escherichia coli O157:H7 infection.","volume":"52","author":"Ikeda","year":"1999","journal-title":"Clin Nephrol"},{"key":"R15-9-20210202","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/jama.288.8.996","article-title":". Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis.","volume":"288","author":"Safdar","year":"2002","journal-title":"JAMA"},{"key":"R16-9-20210202","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1001\/jama.288.8.1014","article-title":"Antimicrobial therapy in patients with Escherichia coli O157:H7 infection.","volume":"288","author":"Molbak","year":"2002","journal-title":"JAMA"},{"key":"R17-9-20210202","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s100960050181","article-title":". Strain-specific differences in the amount of Shiga toxin released from enterohemorrhagic Escherichia coli O157 following exposure to subinhibitory concentrations of antimicrobial agents.","volume":"17","author":"Grif","year":"1998","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R18-9-20210202","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF01704889","article-title":". Effect of subinhibitory concentrations of antibiotics on extracellular Shiga-like toxin I.","volume":"20","author":"Walterspiel","year":"1992","journal-title":"Infection"},{"key":"R20-9-20210202","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/S0140-6736(99)00621-2","article-title":"Induction of type 2 Shiga toxin synthesis in Escherichia coli O157 by 4-quinoloes.","volume":"353","author":"Kimmitt","year":"1999","journal-title":"Lancet"},{"key":"R21-9-20210202","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3201\/eid0605.000503","article-title":"Toxin gene expression by Shiga toxin-producing Escherichia coli: the role of antibiotics and the bacterial SOS response.","volume":"6","author":"Kimmitt","year":"2000","journal-title":"Emerg Infect Dis"},{"key":"R22-9-20210202","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0924-8579(00)00126-6","article-title":". Macrolides and clindamycin suppress the release of Shiga-like toxins from Escherichia coli O157:H7 in vitro.","volume":"15","author":"Murakami","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"R23-9-20210202","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1574-695X.1997.tb01072.x","article-title":"Effect of antimicrobial agents, especially fosfomycin, on the production and release of Vero toxin by enterohaemorrhagic Escherichia coli O157:H7.","volume":"19","author":"Yoh","year":"1997","journal-title":"FEMS Immunol Med Microbiol"},{"key":"R24-9-20210202","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1086\/596509","article-title":". Gnotobiotic piglet infection model for evaluating the safe use of antibiotics against Escherichia coli O157:H7 infection.","volume":"199","author":"Zhang","year":"2009","journal-title":"J Infect Dis"},{"key":"R25-9-20210202","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1086\/315239","article-title":". Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice.","volume":"181","author":"Zhang","year":"2000","journal-title":"J Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006454-201201000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:22:10Z","timestamp":1786047730000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-201201000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e31823096a8","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}